BioSpace News Archive

Bio NC

United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting

Clinical study data suggests Tyvaso® improved forced vital capacity, an important measure of lung function, in patients with pulmonary hypertension associated with interstitial lung disease

October 22, 2020
·
16 min read
Business

Danaher Reports Third Quarter 2020 Results

Danaher Corporation announced results for the quarter ended October 2, 2020.

October 22, 2020
·
25 min read
Business

Theravance Biopharma to Report Third Quarter 2020 Financial Results on November 5, 2020

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its third quarter 2020 financial results and provide a business update after market close on Thursday, November 5, 2020.

October 22, 2020
·
2 min read
Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than Expected

Lexaria Bioscience Corp., a global innovator in oral drug delivery platforms, is pleased to announce that it is exceeding expectations for volume of servings of its patented DehydraTECHTM enabled CBD powders, to be processed during the Company’s fiscal Q1 2021 ending November 30, 2020.

October 22, 2020
·
5 min read
Drug Development

MediciNova, in Collaboration with the University of Sydney and the Australasian Gastro-Intestinal Trials Group, Announces Plans for a Multi-center, Phase 2b Study to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that it plans to initiate a multi-center, placebo-controlled, randomized Phase 2b trial to evaluate MN-166 in chemotherapy-induced peripheral neuropathy.

October 22, 2020
·
7 min read
Genetown

NeuroMetrix Reports Q3 2020 Financial Results

NeuroMetrix, Inc. reported financial and business highlights for the quarter ended September 30, 2020.

October 22, 2020
·
6 min read
Business

Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020

Luminex Corporation announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020.

October 22, 2020
·
1 min read
Business

BD Announces Executive Leadership Appointments

BD, a leading global medical technology company, announced the appointment of Patrick Kaltenbach as executive vice president and chief technology officer, and the promotion of Dave Hickey to executive vice president and president, Life Sciences segment, both effective January 1, 2021.

October 22, 2020
·
5 min read
Business

Lantern Pharma to Host Third Quarter 2020 Operating and Financial Results Conference Call on October 29, 2020 at 4:00 p.m. ET

Lantern Pharma announced that it will host a conference call and live webcast on Thursday, October 29, 2020 at 4:00 p.m. ET to discuss financial and operating results for the third quarter ended September 30, 2020.

October 22, 2020
·
4 min read
Business

Compugen to Release Third Quarter 2020 Results on Thursday, November 5, 2020

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that the Company will release its third quarter 2020 financial results on Thursday, November 5, 2020 before the U.S. financial markets open.

October 22, 2020
·
1 min read